Self-Eating: Friend or Foe? The Emerging Role of Autophagy in Idiopathic Pulmonary Fibrosis

Table 2

Clinical trials targeting autophagy in pulmonary diseases.

Identifier	Condition	Intervention	Phase	Status
NCT00969306	SCLC	Chloroquine, A-CQ100	Phase 1	Not yet recruiting
NCT00933803	NSCLC	Paclitaxel; Carboplatin; Hydroxychloroquine; Bevacizumab	Phase 1; Phase 2	Active; Not recruiting
NCT01649947	NSCLC; Recurrent; NSCLC	Paclitaxel; Carboplatin; Hydroxychloroquine; Bevacizumab	Phase 2	Recruiting
NCT00728845	Recurrent; Advanced; NSCLC	Bevacizumab; Carboplatin; Hydroxychloroquine; Paclitaxel	Phase 1; Phase 2	Terminated
NCT01687179	LAM	Sirolimus and hydroxychloroquine	Phase 1	Recruiting

SCLC: small-cell lung cancer, NSCLC: non-small cell lung cancer, LAM: lymphangioleiomyomatosis.